IBDEI1CT ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22553,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22553,1,1,0)
 ;;=1^96374
 ;;^UTILITY(U,$J,358.3,22553,1,3,0)
 ;;=3^Ther/Diag/Proph IV push, Init
 ;;^UTILITY(U,$J,358.3,22554,0)
 ;;=96375^^102^1046^24^^^^1
 ;;^UTILITY(U,$J,358.3,22554,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22554,1,1,0)
 ;;=1^96375
 ;;^UTILITY(U,$J,358.3,22554,1,3,0)
 ;;=3^Ther/Diag/Proph IV push ea add seql,new drug
 ;;^UTILITY(U,$J,358.3,22555,0)
 ;;=96367^^102^1046^28^^^^1
 ;;^UTILITY(U,$J,358.3,22555,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22555,1,1,0)
 ;;=1^96367
 ;;^UTILITY(U,$J,358.3,22555,1,3,0)
 ;;=3^Ther/Diag/Proph,IV Infusn,Ea add hr seql
 ;;^UTILITY(U,$J,358.3,22556,0)
 ;;=96368^^102^1046^23^^^^1
 ;;^UTILITY(U,$J,358.3,22556,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22556,1,1,0)
 ;;=1^96368
 ;;^UTILITY(U,$J,358.3,22556,1,3,0)
 ;;=3^Ther/Diag/Proph IV Infusn, Concurrent
 ;;^UTILITY(U,$J,358.3,22557,0)
 ;;=96446^^102^1046^4^^^^1
 ;;^UTILITY(U,$J,358.3,22557,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22557,1,1,0)
 ;;=1^96446
 ;;^UTILITY(U,$J,358.3,22557,1,3,0)
 ;;=3^Chemo Admn, Peritoneal Cavity
 ;;^UTILITY(U,$J,358.3,22558,0)
 ;;=J9000^^102^1047^9^^^^1
 ;;^UTILITY(U,$J,358.3,22558,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22558,1,1,0)
 ;;=1^J9000
 ;;^UTILITY(U,$J,358.3,22558,1,3,0)
 ;;=3^Doxorubicin 10mg
 ;;^UTILITY(U,$J,358.3,22559,0)
 ;;=J9031^^102^1047^1^^^^1
 ;;^UTILITY(U,$J,358.3,22559,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22559,1,1,0)
 ;;=1^J9031
 ;;^UTILITY(U,$J,358.3,22559,1,3,0)
 ;;=3^B C G (Intravesical)
 ;;^UTILITY(U,$J,358.3,22560,0)
 ;;=J9040^^102^1047^2^^^^1
 ;;^UTILITY(U,$J,358.3,22560,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22560,1,1,0)
 ;;=1^J9040
 ;;^UTILITY(U,$J,358.3,22560,1,3,0)
 ;;=3^Bleomycin Sulfate Inj 15U
 ;;^UTILITY(U,$J,358.3,22561,0)
 ;;=J9045^^102^1047^4^^^^1
 ;;^UTILITY(U,$J,358.3,22561,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22561,1,1,0)
 ;;=1^J9045
 ;;^UTILITY(U,$J,358.3,22561,1,3,0)
 ;;=3^Carboplatin 50mg
 ;;^UTILITY(U,$J,358.3,22562,0)
 ;;=J9060^^102^1047^5^^^^1
 ;;^UTILITY(U,$J,358.3,22562,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22562,1,1,0)
 ;;=1^J9060
 ;;^UTILITY(U,$J,358.3,22562,1,3,0)
 ;;=3^Cisplatin 10 MG injection
 ;;^UTILITY(U,$J,358.3,22563,0)
 ;;=J9100^^102^1047^7^^^^1
 ;;^UTILITY(U,$J,358.3,22563,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22563,1,1,0)
 ;;=1^J9100
 ;;^UTILITY(U,$J,358.3,22563,1,3,0)
 ;;=3^Cytarabine (arac) 100mg
 ;;^UTILITY(U,$J,358.3,22564,0)
 ;;=J9181^^102^1047^11^^^^1
 ;;^UTILITY(U,$J,358.3,22564,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22564,1,1,0)
 ;;=1^J9181
 ;;^UTILITY(U,$J,358.3,22564,1,3,0)
 ;;=3^Etoposide (VP 16) 10mg
 ;;^UTILITY(U,$J,358.3,22565,0)
 ;;=J9185^^102^1047^12^^^^1
 ;;^UTILITY(U,$J,358.3,22565,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22565,1,1,0)
 ;;=1^J9185
 ;;^UTILITY(U,$J,358.3,22565,1,3,0)
 ;;=3^Fludarabine 50mg
 ;;^UTILITY(U,$J,358.3,22566,0)
 ;;=J9190^^102^1047^13^^^^1
 ;;^UTILITY(U,$J,358.3,22566,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22566,1,1,0)
 ;;=1^J9190
 ;;^UTILITY(U,$J,358.3,22566,1,3,0)
 ;;=3^Fluorouracil 500mg
 ;;^UTILITY(U,$J,358.3,22567,0)
 ;;=J9201^^102^1047^14^^^^1
 ;;^UTILITY(U,$J,358.3,22567,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22567,1,1,0)
 ;;=1^J9201
 ;;^UTILITY(U,$J,358.3,22567,1,3,0)
 ;;=3^Gemcitabine 200mg
 ;;^UTILITY(U,$J,358.3,22568,0)
 ;;=J9202^^102^1047^15^^^^1
 ;;^UTILITY(U,$J,358.3,22568,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22568,1,1,0)
 ;;=1^J9202
 ;;^UTILITY(U,$J,358.3,22568,1,3,0)
 ;;=3^Goserelin, per 3.6mg
